英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Biotech Company - Juvenescence
    Juvenescence is a clinical-stage drug development company dedicated to extending healthy lifespan through innovative medicines Our approach centres around developing medicines that target core pathways of aging to not only treat but prevent age-related diseases, ensuring that longevity comes with enhanced quality of life By focusing on early disease intervention and prevention, we are
  • Our Team - Juvenescence
    Leaders in Biopharmaceutical Innovation Our leadership team is a coalition of disruptors with over 150 years of combined R D experience and a history of delivering two of the 10 largest biopharma deals of the last century They are committed to advancing the future of medicine, creating approved medicines, and consistently delivering value to our shareholders
  • Juvenescence Completes Phase 1 Trial of PAI-1 Inhibitor
    Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership PAI-1 Inhibitor (MDI-2517) demonstrates good safety and tolerability profile, with Phase 2 proof-of-concept trial planned for in patients with metabolic and fibrotic disease Carmel Nanthakumar, PhD, joins as VP, Translational Biology, following recent appointments of
  • News - Juvenescence
    M42 announces a strategic investment and partnership with Juvenescence, a leading biotech company focused on extending human healthspan This collaboration aims to develop cutting-edge therapies and advance research in longevity and age-related diseases
  • Our Pipeline - Juvenescence
    Our core medicines (JuvTherapeutics) are comprised of therapeutics developed by the Juvenescence team, targeting fundamental aging mechanisms with a near-term age-related first indication identified for clinical development
  • Dr Gregory Bailey Md - Juvenescence
    Dr Greg Bailey, MDExecutive Chairman Co-Founder Dr Greg Bailey, MD, a co-founder and the Executive Chairman of Juvenescence, is a physician, financier, and biotech entrepreneur with extensive experience founding and financing healthcare companies Dr Bailey is driven by the important opportunity to truly modify aging based on rigorous science The goal: to use his track
  • Juvenescence, The Buck Institute, and Insilico Medicine establish Napa . . .
    Juvenescence, The Buck Institute for Research on Aging, and Insilico Medicine announced today that they have formed Napa Therapeutics, Ltd to develop drugs against a novel aging-related target The Buck Institute is one of the leading research centers in the world focused solely on research on aging and the elimination of age-related disease
  • Juvenescence Appoints Eileen Jennings-Brown as CTO and Strengthens UAE . . .
    Abu Dhabi, UAE, 16 February 2026: Juvenescence Limited, a clinical-stage AI-enabled biotech company developing novel medicines to extend healthy lifespan, today announced the appointment of Eileen Jennings-Brown as Chief Technology Officer, and a significant expansion of its operations in the United Arab Emirates through the establishment of
  • February 26, 2026 - Juvenescence
    Juvenescence successfully completes Phase 1 clinical trial of PAI-1 inhibitor and strengthens clinical development leadership PAI-1 Inhibitor (MDI-2517) demonstrates good safety and […]
  • Jim Mellon - Juvenescence
    Jim MellonDeputy Chairman Co-Founder Jim Mellon, a co-founder and Deputy Chairman of Juvenescence, was inspired by the possibilities and advances being made in the area of longevity He travelled across the world, speaking to leading scientists and researchers, and from those conversations, he wrote the book, Juvenescence That book and his partnership with Greg Bailey





中文字典-英文字典  2005-2009